| 摘要: |
| 金花清感颗粒研发于甲型H1N1流感病毒疫情盛行时期，其组方以经典名方银翘散和麻杏石甘汤为主体传承创新而成，主治病机为风温初起、卫气同病，其中知母为组方的点睛之笔，起到坚阴护卫之效。金花清感颗粒在新型冠状病毒感染疫情防治中均展现出很高的临床疗效，其在新型冠状病毒感染防治中主要针对的证型为：燥伏太阴、伏燥兼湿、卫气同病，进一步强调了伏燥病机在新型冠状病毒感染发病中的重要性，为今后的防治提供了新思路。 |
| 关键词: 金花清感颗粒 新型冠状病毒感染 伏燥 知母 |
| DOI：10.11656/j.issn.1673-9043.2024.09.01 |
| 分类号:R254 |
| 基金项目:中华人民共和国科学技术部"重大新药创制"项目(2017ZX09304019)。 |
|
| Theoretical analysis of Jinhua Qinggan Granules in the treatment of Corona Virus Disease 2019 |
|
SHI Naixin, WU Shengxian
|
|
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China
|
| Abstract: |
| Jinhua Qinggan Granule was developed in the epidemic period of influenza(H1N1),and its formulation is mainly composed of the classic prescription yinqiao powder and Maxing Shigantang Decoction. The pathogenesis is the internal dryness and wind heat attack the lungs,and anemarrhena asphodeloides is the punchline of the formulation,which plays the effect of strengthening yin and guarding wei. Jinhua Qinggan Granules have shown high clinical efficacy in the prevention and treatment of Corona Virus Disease 2019(COVID-19). In the prevention and treatment of mild cases of COVID-19,the main syndrometypes targeted by Jinhua Qinggan Granules are:dry latent taiyin,dry and wet,and wei qi co-morbidity,which further emphasizes the importance of the pathogenesis of dry and latent in the pathogenesis of influenza and provides a new idea for the prevention and treatment of influenza in the future. |
| Key words: Jinhua Qinggan Granule Corona Virus Disease 2019 fuzao anemarrhena asphodeloides |
